Biofeedback Electromyography Training versus Botulinum Toxin A on Synkinesis and Facial Asymmetry in Bell's Palsy

Not Applicable

• Conditions: Nervous System Diseases

• Registration Number: PACTR201811856336735
• Lead Sponsor: Cairo university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-11-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

•All patients have Bell's palsy for at least 4-6 months together with a form of synkinesis (ocular or oral).
•All patients have long-term rehabilitation poor prognosisand gradual improvement.
•All patients will have moderate degree of facial synkinesis and asymmetry according to Synkinesis Assessment Questionnaire
•All patients will be assessed by the Sunnybrook Facial Grading System and House-Brackmann scale to detect degree of synkinesis pre and post treatment
•All patients will clinically and medically stable when attending and during the study.
•Age will range from 30-60.

Exclusion Criteria

•Upper motor neuron facial nerve palsy.
•History of seizures or fainting.
•keratitis, or other ocular diseases
•anticoagulant therapy,
•Pregnancy, breast-feeding.
• Active infection in the area to be treated, neuromuscular junction disorders, or known hypersensitivity to any BoNT-A constituent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The Sunnybrook Facial Grading System

Secondary Outcome Measures

Name	Time	Method
The House Brackmann scale <br>